Stillwater Investment Management (Minnesota)’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $3.25M | Buy |
39,201
+464
| +1% | +$38.4K | 0.87% | 27 |
|
|
2022
Q4 | $3.33M | Buy |
38,737
+320
| +0.8% | +$25.3K | 0.94% | 27 |
|
|
2022
Q3 | $2.37M | Buy |
38,417
+429
| +1% | +$27.1K | 0.73% | 34 |
|
|
2022
Q2 | $2.35M | Sell |
37,988
-533
| -1% | -$33K | 0.69% | 36 |
|
|
2022
Q1 | $2.29M | Buy |
38,521
+75
| +0.2% | +$4.79K | 0.58% | 39 |
|
|
2021
Q4 | $2.79M | Buy |
38,446
+421
| +1% | +$29K | 0.69% | 34 |
|
|
2021
Q3 | $2.66M | Buy |
38,025
+237
| +0.6% | +$16.6K | 0.71% | 36 |
|
|
2021
Q2 | $2.6M | Sell |
37,788
-154
| -0.4% | -$10.3K | 0.69% | 37 |
|
|
2021
Q1 | $2.45M | Buy |
37,942
+969
| +3% | +$62.5K | 0.7% | 38 |
|
|
2020
Q4 | $2.15M | Sell |
36,973
-3,773
| -9% | -$228K | 0.66% | 38 |
|
|
2020
Q3 | $2.58M | Buy |
40,746
+595
| +1% | +$41.3K | 0.93% | 29 |
|
|
2020
Q2 | $3.09M | Buy |
40,151
+465
| +1% | +$35.6K | 1.22% | 19 |
|
|
2020
Q1 | $2.97M | Buy |
39,686
+537
| +1% | +$37.1K | 1.41% | 17 |
|
|
2019
Q4 | $2.54M | Buy |
39,149
+222
| +0.6% | +$14.5K | 0.96% | 33 |
|
|
2019
Q3 | $2.47M | Sell |
38,927
-691
| -2% | -$45.2K | 1.03% | 28 |
|
|
2019
Q2 | $2.68M | Sell |
39,618
-2,950
| -7% | -$194K | 1.12% | 24 |
|
|
2019
Q1 | $2.77M | Buy |
42,568
+696
| +2% | +$46.3K | 1.13% | 23 |
|
|
2018
Q4 | $2.62M | Sell |
41,872
-1,811
| -4% | -$127K | 1.22% | 21 |
|
|
2018
Q3 | $3.37M | Buy |
43,683
+132
| +0.3% | +$9.97K | 1.36% | 15 |
|
|
2018
Q2 | $3.08M | Buy |
43,551
+260
| +0.6% | +$18.4K | 1.33% | 16 |
|
|
2018
Q1 | $3.26M | Buy |
43,291
+2,585
| +6% | +$205K | 1.42% | 14 |
|
|
2017
Q4 | $2.92M | Buy |
40,706
+3,355
| +9% | +$255K | 1.77% | 19 |
|
|
2017
Q3 | $3.03M | Buy |
37,351
+591
| +2% | +$45.2K | 1.38% | 14 |
|
|
2017
Q2 | $2.6M | Buy |
36,760
+117
| +0.3% | +$7.79K | 1.23% | 19 |
|
|
2017
Q1 | $2.49M | Buy |
36,643
+29
| +0.1% | +$2.04K | 1.19% | 18 |
|
|
2016
Q4 | $2.62M | Sell |
36,614
-717
| -2% | -$53.3K | 1.35% | 15 |
|
|
2016
Q3 | $2.95M | Buy |
37,331
+2,400
| +7% | +$195K | 1.6% | 12 |
|
|
2016
Q2 | $2.91M | Buy |
34,931
+216
| +0.6% | +$19.2K | 1.66% | 13 |
|
|
2016
Q1 | $3.19M | Buy |
34,715
+1,169
| +3% | +$105K | 1.89% | 9 |
|
|
2015
Q4 | $3.4M | Buy |
33,546
+324
| +1% | +$33.7K | 2.12% | 7 |
|
|
2015
Q3 | $3.26M | Buy |
33,222
+94
| +0.3% | +$10.4K | 2.19% | 5 |
|
|
2015
Q2 | $3.88M | Buy |
33,128
+293
| +0.9% | +$32K | 2.46% | 5 |
|
|
2015
Q1 | $3.22M | Buy |
32,835
+280
| +0.9% | +$28.4K | 2.07% | 5 |
|
|
2014
Q4 | $3.07M | Sell |
32,555
-848
| -3% | -$87.7K | 2.07% | 6 |
|
|
2014
Q3 | $3.56M | Sell |
33,403
-930
| -3% | -$91.1K | 2.5% | 5 |
|
|
2014
Q2 | $2.85M | Sell |
34,333
-470
| -1% | -$36.6K | 2.05% | 6 |
|
|
2014
Q1 | $2.47M | Sell |
34,803
-165
| -0.5% | -$12.9K | 1.88% | 8 |
|
|
2013
Q4 | $2.63M | Buy |
+34,968
| New | +$2.43M | 2.01% | 7 |
|
Other funds holding GILD
Stillwater Investment Management (Minnesota)'s GILD Position: Q1 2023 in Review
Stillwater Investment Management (Minnesota) increased its Gilead Sciences (GILD) stake by 1.2% in Q1 2023, buying an estimated $38.4K and bringing the position to 39,201 shares worth $3.25M. The position accounts for 0.87% of the portfolio, ranked #27.
Stillwater Investment Management (Minnesota) first reported a position in GILD in Q4 2013 and has held it in 38 quarters since. The position peaked at $3.88M in Q2 2015. 1,736 funds tracked by Wall St. Rank hold GILD as of Q1 2023.
- Stillwater Investment Management (Minnesota) held 39,201 shares of Gilead Sciences worth $3.25M as of Q1 2023.
- Stillwater Investment Management (Minnesota) bought 464 Gilead Sciences shares in Q1 2023, an estimated $38.4K.
- Gilead Sciences made up 0.87% of Stillwater Investment Management (Minnesota)'s portfolio in Q1 2023, its #27 holding.
- Stillwater Investment Management (Minnesota) first reported a position in Gilead Sciences in Q4 2013 and has held it in 38 quarters since.
- Stillwater Investment Management (Minnesota)'s Gilead Sciences position peaked at $3.88M in Q2 2015.
- 1,736 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2023.
Based on Stillwater Investment Management (Minnesota)'s 13F filing for Q1 2023, filed 5 Apr 2023.